1-10 of 10
Arend Stackelberg
Close
Sort by
Journal Articles

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia Relapsing after Allogeneic Stem Cell Transplantation

Jessica I Hoell, MD, Sebastian Ginzel, MSc, Cornelia Eckert, PhD, Michael Gombert, PhD, Ute Fischer, PhD, Martin Stanulla, MD, Martin Schrappe, MD PhD, Udo zur Stadt, PhD, Peter Bader, MD, Brigitte Strahm, MD, Julia Alten, Anja Moericke, MD, Gabriele Escherich, MD, Arend Stackelberg, MD, Christina Peters, MD, Arndt Borkhardt, MD, Roland Meisel, MD
Journal: Blood
Blood (2016) 128 (22): 601.
https://doi.org/10.1182/blood.V128.22.601.601
Published: 2016
Journal Articles

Validation of MRD Quantification By Flow Cytometry for Pediatric BCP ALL Relapsed Patients Treated on the Intreall Protocol

Ester Mejstrikova, MD PhD, Julie Irving, Leonid Karawajew, Marian Case, Jenny Jesson, Vaskar Saha, PhD FRCP, FRCPath, Nicholas Goulden, MD PhD, Jeremy Hancock, PhD, Arend Stackelberg, MD, Sarah Lawson, Michael Dworzak, MD, Renate Panzer-Grumayer, Barbara Buldini, Lisa Eyre, Giuseppe Basso, MD, Maddalena Paganin, Jan Trka, Daniela Kužílková, Jan Stary, Lucie Sramkova, MD, Ondrej Hrusak, MD PhD, Cornelia Eckert
Journal: Blood
Blood (2015) 126 (23): 1414.
https://doi.org/10.1182/blood.V126.23.1414.1414
Published: 2015
Journal Articles

Phase II Study on Bortezomib (BTZ) in Multiple Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (rALL): High Response Rate with a Modestly Intensive Regimen Including BTZ, Not Related to Pharmacokinetics

Gertjan J.L. Kaspers, MD PhD, Denise Niewerth, PhD, Bram Wilhelm, PharmD, Satianand Ramnarain, MSc, Hans Berkhof, PhD, Valerie De Haas, MD PhD, Ron A.A. Mathôt, PharmD, PhD, Andishe Attarbaschi, MD, Andre Baruchel, MD, Eveline S. de Bont, Franca Fagioli, MD, Claudia Rossig, MD, Thomas Klingebiel, MD, Barbara De Moerloose, MD PhD, Brigitte Nelken, MD, Giuseppe Palumbo, MD, Dirk Reinhardt, MD, Pierre Simon Rohrlich, MD, Pauline Simon, MD, Arend Stackelberg, MD, C. Michel Zwaan, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2501.
https://doi.org/10.1182/blood.V126.23.2501.2501
Published: 2015
Journal Articles

Drug Response Profiling to Identify Selective Pharmacological Activity in Drug Resistant ALL

Viktoras Frismantas, MSc, Maria Pamela Dobay, PhD, Anna Rinaldi, PhD, Kunz Joachim, MD, Blerim Marovca, Peter Horvath, PhD, Mauro Delorenzi, PhD, Gunnar Cario, MD, Martin Schrappe, MD, Martin Stanulla, MD, Andreas E. Kulozik, MD PhD, Martina U. Muckenthaler, PhD, Arend Stackelberg, MD, Cornelia Eckert, Thomas Radimerski, PhD, Beat Bornhauser, PhD, Jean-Pierre Bourquin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2532.
https://doi.org/10.1182/blood.V126.23.2532.2532
Published: 2015
Journal Articles

Bilateral Involvement Is an Independent Risk Factor in Testicular Relapse of Childhood ALL: Results of the Trials ALL-REZ BFM 83 - 2002

Christiane Chen-Santel, MD, Ulrike Tabien, MD, Claudia van Schewick, MD, Martin Schrappe, MD, Gabriele Escherich, MD, Angelika Eggert, MD, Günter Henze, MD, Arend Stackelberg, MD, Patrick Hundsdörfer, MD
Journal: Blood
Blood (2014) 124 (21): 66.
https://doi.org/10.1182/blood.V124.21.66.66
Published: 2014
Journal Articles

RAS Pathway Mutations Are Highly Prevalent In Relapsed Childhood Acute Lymphoblastic Leukaemia, Are Frequently Relapse-Drivers and Confer Sensitivity To MEK Inhibition

Julie Irving, PhD, Elizabeth C. Matheson, MPhil, Lynne Minto, Helen Blair, PhD, Marian Case, MSc, Christina Halsey, MD, PhD, Isabella Swidenbank, MRes, Frida Ponthan, PhD, Renate Kirschner-Schwabe, PhD, Stefanie Groeneveld-Krentz, MSc, Jana Hof, MSc, James Allan, PhD, Christine J. Harrison, PhD, Josef Vormoor, MD, Arend Stackelberg, MD, Cornelia Eckert, PhD
Journal: Blood
Blood (2013) 122 (21): 823.
https://doi.org/10.1182/blood.V122.21.823.823
Published: 2013
Journal Articles

Preventive CNS Irradiation with 12 Gy Compared to 18 Gy: Results of Studies AML-BFM 98 and 2004.

Ursula Creutzig, MD, Martin Zimmermann, PhD, Joerg Ritter, MD, Norbert Graf, MD, Thomas Lehrnbecher, Jean-Pierre Bourquin, MD, PhD, Arend Stackelberg, Michael N Dworzak, MD, PhD, Jan Starý, MD, Dirk Reinhardt, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 483.
https://doi.org/10.1182/blood.V114.22.483.483
Published: 2009
Journal Articles

Significant Reduction of Treatment Related Mortality after Stem Cell Transplantation in 647 Children and Adolescents with ALL within BFM Trials during the Last 12 Years: A Long Term Analysis from 1996 to 2007

André Schrauder, Martin Schrappe, Arend Stackelberg, Peter Bader, Wolfgang Holter, Rupert Handgretinger, Wolfram Ebell, Dagmar Dilloo, Tayfun Güngör, Monika Fuehrer, Hartmut Kabisch, Martin Zimmermann, Ulrike Poetschger, Karl-Walter Sykora, Christina Peters
Journal: Blood
Blood (2008) 112 (11): 567.
https://doi.org/10.1182/blood.V112.11.567.567
Published: 2008
Journal Articles

Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002

Cornelia Eckert, PhD, Arend Stackelberg, MD, Nikola Hagedorn, Andrea Barth, Karl Seeger, MD, PhD, Guenter Henze, MD
Journal: Blood
Blood (2008) 112 (11): 2515.
https://doi.org/10.1182/blood.V112.11.2515.2515
Published: 2008
Journal Articles

The Importance of Harmonizing Transplantation Procedures in Children with ALL: ALL-SCT-BFM 2003, a Prospective Multicenter Trial.

André Schrauder, MD, Arend Stackelberg, MD, Martin Schrappe, MD, Thomas Klingebiel, MD, Wolfgang Holter, MD, Karl-Walter Sykora, MD, Rupert Handgretinger, MD, Wolfram Ebell, MD, Ulrike Pötschger, PhD, Martin Zimmermann, PhD, Susanne Karlhuber, PhD, Christina Peters, MD
Journal: Blood
Blood (2007) 110 (11): 1099.
https://doi.org/10.1182/blood.V110.11.1099.1099
Published: 2007